Terms ending in 2035
Every in-force patent on Genentech, Inc.'s record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,563,161 | Bioreactors with Multiple or Adjustable-Position Agitator Designs In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 11,186,650 | ANTI-CD3 Antibodies and Methods of Use In force · Medium confidence | Genentech, Inc. | In force | Medium confidence | |
| US 9,763,942 | Serine/Threonine Kinase Inhibitors In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 9,518,121 | ANTI-JAGGED1 Antibodies and Methods of Use In force · High confidence | F. Hoffmann-La Roche AG | In force | High confidence | |
| US 12,409,064 | Method and Apparatus for Suprachoroidal Administration of Therapeutic Agent In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 10,150,813 | ANTI-B7-H4 Antibodies and Immunoconjugates In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 10,889,651 | ANTI-Ly6E ANTIBODIES AND METHODS OF USE In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 10,683,348 | Dual Specific Antibodies In force · Medium confidence | Genentech, Inc. | In force | Medium confidence | |
| US 10,435,694 | Methods and Compositions for Secretion of Heterologous Polypeptides In force · High confidence | Genentech, Inc. | In force | High confidence | |
| US 11,135,303 | Pyrrolobenzodiazepines and Conjugates Thereof In force · High confidence | MedImmune Limited | In force | High confidence | |
| 89 more term ends in 2035 · Pro | |||||
10 of 99 patents shown. Soonest term end first, then patent number.
Pro members see all 99.
89 of these are in force and held by Genentech, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.